Research reports examining cytokines in the skin of patients with ICI-induced cutaneous symptoms have found increased production of Th2 cytokines such as IL-4, IL-5, and IL-13 in cases of urticaria, pruritus, and eczema [101]. This evidence concerns the gene IL13 and Eczematoid dermatitis.